ArticleFrontiers in immunology2024

An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma.

Yunqian Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.